 | Dr. Reddy's Inks Deal to Sell Neurology Branded Products
finance.yahoo.com - June 14 at 6:29 PM |
 | Critical Analysis: Acorda Therapeutics (NASDAQ:ACOR) versus Avrobio (NASDAQ:AVRO)
www.americanbankingnews.com - June 14 at 12:15 PM |
 | Acorda Therapeutics Enters Oversold Territory
www.nasdaq.com - June 13 at 7:13 PM |
| Catalyst Pharma Files Lawsuit Against FDA Approval of Ruzurgi
finance.yahoo.com - June 13 at 7:13 PM |
 | Denali's Hunter Syndrome Candidate Gets Orphan Drug Status
www.msn.com - June 12 at 11:46 AM |
| Acorda Therapeutics Inc (ACOR) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - June 5 at 10:13 AM |
| Celldex Presents Data From CDX-3379 Study at ASCO, Stock Down
www.msn.com - June 4 at 6:16 PM |
| Seattle Genetics, Astellas' Cancer Candidate Attains 44% ORR
finance.yahoo.com - June 4 at 6:16 PM |
 | Theravance Biopharma Appoints Andrew Hindman as Senior Vice President and Chief Financial Officer
www.marketwatch.com - June 4 at 9:06 AM |
| Acorda Therapeutics Debuts Art Exhibition Inspired by People with Parkinson’s at the 5th World Parkinson Congress
finance.yahoo.com - June 3 at 8:58 AM |
| Acorda (ACOR) Down 11.3% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - June 1 at 5:10 PM |
| Mesoblast Starts Rolling BLA Submission for Remestemcel-L
finance.yahoo.com - May 30 at 6:08 PM |
| Fate Therapeutics (FATE) Surges: Stock Moves 6.8% Higher
finance.yahoo.com - May 29 at 6:27 PM |
| Acorda Therapeutics Inc (ACOR) Expected to Announce Quarterly Sales of $25.23 Million
www.americanbankingnews.com - May 28 at 1:26 AM |
| Zacks: Brokerages Expect Acorda Therapeutics Inc (ACOR) Will Post Earnings of -$1.02 Per Share
www.americanbankingnews.com - May 26 at 10:13 PM |
| Acorda Therapeutics to Present at Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 23 at 9:05 AM |
| Acorda Therapeutics (ACOR) Research Coverage Started at Wedbush
www.americanbankingnews.com - May 22 at 6:22 PM |
| Acorda Therapeutics (ACOR) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 4 at 5:12 PM |
| Edited Transcript of ACOR earnings conference call or presentation 2-May-19 12:30pm GMT
finance.yahoo.com - May 3 at 9:09 AM |
| Parkinsons Disease Drugs And Therapeutics Market Size, key Manufacturers, Application, Type, End-user, Forecast to 2028
www.marketwatch.com - May 2 at 9:07 AM |
 | Acorda Q4 Ampyra sales down 60% on generic encroachment
seekingalpha.com - May 2 at 9:07 AM |
| Acorda Therapeutics (ACOR) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 2 at 9:07 AM |
| Acorda Therapeutics Q1 2019 Earnings Preview
seekingalpha.com - May 1 at 6:55 PM |
| Earnings Preview: Acorda Therapeutics (ACOR) Q1 Earnings Expected to Decline
finance.yahoo.com - April 25 at 6:37 PM |
| Should You Be Concerned About Acorda Therapeutics, Inc.'s (NASDAQ:ACOR) Historical Volatility?
finance.yahoo.com - April 22 at 5:45 PM |
| Acorda First Quarter 2019 Update: Webcast/Conference Call Scheduled for May 2, 2019
finance.yahoo.com - April 18 at 6:55 PM |
 | A startup just raised $27 million to make a new kind of painkiller using technology from Harvard scientists, as the race to replace opioids heats up
www.businessinsider.com - April 17 at 6:46 PM |
 | Acorda Therapeutics (ACOR) to Present New Long-Term Data for INBRIJA at AMCP - StreetInsider.com
www.streetinsider.com - March 19 at 6:59 PM |
| Acorda to Present New Long-Term Data for INBRIJA™ (levodopa inhalation powder) at Academy of Managed Care Pharmacy Annual Meeting
finance.yahoo.com - March 19 at 9:22 AM |
| Acorda Therapeutics, Inc. (ACOR) After Hours Trading
www.nasdaq.com - March 18 at 7:08 PM |
 | Acorda Therapeutics Inc
www.bloomberg.com - March 18 at 7:08 PM |
| Acorda (ACOR) Down 6% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - March 16 at 6:17 PM |
| Should You Be Concerned About Acorda Therapeutics, Inc.’s (NASDAQ:ACOR) ROE?
finance.yahoo.com - March 15 at 6:53 PM |
| Acorda Therapeutics (ACOR) Gains But Lags Market: What You Should Know
finance.yahoo.com - March 15 at 6:53 PM |
| Acorda Therapeutics chief business officer bids adieu
seekingalpha.com - March 8 at 9:12 AM |
| Acorda Therapeutics Announces Management Changes
finance.yahoo.com - March 8 at 9:12 AM |
 | Acorda to Present at Oppenheimer's 29th Annual Healthcare Conference - Business Wire
www.businesswire.com - March 7 at 6:19 PM |
 | Glancy Prongay & Murray LLP Announces Investigation on Behalf of Acorda Therapeutics, Inc. Investors (ACOR) - GlobeNewswire
globenewswire.com - March 6 at 9:13 AM |
| Glancy Prongay & Murray LLP Announces Investigation on Behalf of Acorda Therapeutics, Inc. Investors (ACOR)
finance.yahoo.com - March 6 at 9:13 AM |
| Acorda to Present at Oppenheimer’s 29th Annual Healthcare Conference
finance.yahoo.com - March 6 at 9:13 AM |
| Acorda launches Inbrija in U.S.
seekingalpha.com - February 28 at 6:30 PM |
| Acorda Therapeutics Announces Commercial Launch of INBRIJA™ (levodopa inhalation powder)
finance.yahoo.com - February 28 at 6:30 PM |
| Acorda Therapeutics to Present at Cowen Annual Health Care Conference - Business Wire
www.businesswire.com - February 26 at 6:09 PM |
| Parkinsons Disease Drugs And Therapeutics Market 2019 Global Analysis, Opportunities and Forecast to 2028
www.marketwatch.com - February 26 at 9:20 AM |
| Acorda Therapeutics to Present at Cowen Annual Health Care Conference
finance.yahoo.com - February 26 at 9:20 AM |
| Acorda Therapeutics Becomes Oversold
www.nasdaq.com - February 20 at 6:18 PM |
| Acorda Therapeutics to Present at Leerink Global Healthcare Conference
finance.yahoo.com - February 19 at 9:17 AM |
| Edited Transcript of ACOR earnings conference call or presentation 14-Feb-19 9:30pm GMT
finance.yahoo.com - February 18 at 5:35 PM |
| Acorda (ACOR) Q4 Earnings and Revenues Surpass Estimates - Nasdaq
www.nasdaq.com - February 16 at 8:55 AM |
| Acorda Therapeutics, Inc. 2019 Q4 - Results - Earnings Call Slides - Seeking Alpha
seekingalpha.com - February 16 at 8:55 AM |
